State-Level Disparity in Lung Cancer Survival in the United States

Rationale: The cancer mortality-to-incidence ratio (MIR) can serve as a population-based indicator for cancer care outcomes. In the US, evaluation of lung cancer survival by individual states has not been evaluated.Objective: To assess the association between lung cancer survival by using MIRs and s...

Full description

Bibliographic Details
Main Authors: Yu-Che Lee, Rafael A. Calderon-Candelario, Gregory E. Holt, Michael A. Campos, Mehdi Mirsaeidi
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01449/full
id doaj-d94f176c36724e04bae9671b58e88c7e
record_format Article
spelling doaj-d94f176c36724e04bae9671b58e88c7e2020-11-25T03:39:12ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-08-011010.3389/fonc.2020.01449566849State-Level Disparity in Lung Cancer Survival in the United StatesYu-Che Lee0Yu-Che Lee1Yu-Che Lee2Rafael A. Calderon-Candelario3Rafael A. Calderon-Candelario4Gregory E. Holt5Gregory E. Holt6Michael A. Campos7Michael A. Campos8Mehdi Mirsaeidi9Mehdi Mirsaeidi10Mehdi Mirsaeidi11Division of Pulmonary and Critical Care Medicine, University of Miami Miller School of Medicine, Miami, FL, United StatesSection of Pulmonary Medicine, Miami Veterans Affairs Healthcare System, Miami, FL, United StatesDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, United StatesDivision of Pulmonary and Critical Care Medicine, University of Miami Miller School of Medicine, Miami, FL, United StatesSection of Pulmonary Medicine, Miami Veterans Affairs Healthcare System, Miami, FL, United StatesDivision of Pulmonary and Critical Care Medicine, University of Miami Miller School of Medicine, Miami, FL, United StatesSection of Pulmonary Medicine, Miami Veterans Affairs Healthcare System, Miami, FL, United StatesDivision of Pulmonary and Critical Care Medicine, University of Miami Miller School of Medicine, Miami, FL, United StatesSection of Pulmonary Medicine, Miami Veterans Affairs Healthcare System, Miami, FL, United StatesDivision of Pulmonary and Critical Care Medicine, University of Miami Miller School of Medicine, Miami, FL, United StatesSection of Pulmonary Medicine, Miami Veterans Affairs Healthcare System, Miami, FL, United StatesDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, United StatesRationale: The cancer mortality-to-incidence ratio (MIR) can serve as a population-based indicator for cancer care outcomes. In the US, evaluation of lung cancer survival by individual states has not been evaluated.Objective: To assess the association between lung cancer survival by using MIRs and state-level health disparities in the United States.Methods: We calculated 5-year lung cancer MIR averages from 2011 to 2015 using the United States Cancer Statistics (USCS) data. America's Health Rankings (AHR) is a platform using weighted measures in five different categories to calculate annual state health rankings. Five-year averages from 2011 to 2015 of the health uninsured rate and 4-year averages from 2011 to 2014 of health spending per capita were obtained from the U.S. Census Bureau and Centers for Medicare & Medicaid Services. Linear regression analyses were performed to determine the associations between cancer survival value (CSV) = (1 – MIR) × 100% and state health variables.Results: During the study period, the 5-year averages of age-adjusted incidence, mortality rates, and CSVs were 60.3 ± 2.1 per 100,000 population, 43.4 ± 2.1 per 100,000, and 27.9 ± 3.9%, respectively. Among the 50 states, Connecticut had the highest CSV (38.6 ± 1.7%) whereas Nevada had the lowest CSV (18.7 ± 6.5%). Hawaii had the highest health ranking and Mississippi had the lowest ranking in 2016. States with better health rankings, lower health uninsured rates, and higher health spending were significantly associated with higher CSVs (R2 = 0.418, P < 0.001; R2 = 0.352, P < 0.001; R2 = 0.142, P = 0.007, respectively).Conclusions: There are significant differences in lung cancer survival within the United States. Lung cancer survival by using CSV was strongly associated with state health disparities, and it can be an applicable measure to evaluate the state-level health disparities in the United States.https://www.frontiersin.org/article/10.3389/fonc.2020.01449/fulllung cancer survivalAmerica's Health Rankingshealth economy (source: MeSH NLM)insurancedisparity
collection DOAJ
language English
format Article
sources DOAJ
author Yu-Che Lee
Yu-Che Lee
Yu-Che Lee
Rafael A. Calderon-Candelario
Rafael A. Calderon-Candelario
Gregory E. Holt
Gregory E. Holt
Michael A. Campos
Michael A. Campos
Mehdi Mirsaeidi
Mehdi Mirsaeidi
Mehdi Mirsaeidi
spellingShingle Yu-Che Lee
Yu-Che Lee
Yu-Che Lee
Rafael A. Calderon-Candelario
Rafael A. Calderon-Candelario
Gregory E. Holt
Gregory E. Holt
Michael A. Campos
Michael A. Campos
Mehdi Mirsaeidi
Mehdi Mirsaeidi
Mehdi Mirsaeidi
State-Level Disparity in Lung Cancer Survival in the United States
Frontiers in Oncology
lung cancer survival
America's Health Rankings
health economy (source: MeSH NLM)
insurance
disparity
author_facet Yu-Che Lee
Yu-Che Lee
Yu-Che Lee
Rafael A. Calderon-Candelario
Rafael A. Calderon-Candelario
Gregory E. Holt
Gregory E. Holt
Michael A. Campos
Michael A. Campos
Mehdi Mirsaeidi
Mehdi Mirsaeidi
Mehdi Mirsaeidi
author_sort Yu-Che Lee
title State-Level Disparity in Lung Cancer Survival in the United States
title_short State-Level Disparity in Lung Cancer Survival in the United States
title_full State-Level Disparity in Lung Cancer Survival in the United States
title_fullStr State-Level Disparity in Lung Cancer Survival in the United States
title_full_unstemmed State-Level Disparity in Lung Cancer Survival in the United States
title_sort state-level disparity in lung cancer survival in the united states
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2020-08-01
description Rationale: The cancer mortality-to-incidence ratio (MIR) can serve as a population-based indicator for cancer care outcomes. In the US, evaluation of lung cancer survival by individual states has not been evaluated.Objective: To assess the association between lung cancer survival by using MIRs and state-level health disparities in the United States.Methods: We calculated 5-year lung cancer MIR averages from 2011 to 2015 using the United States Cancer Statistics (USCS) data. America's Health Rankings (AHR) is a platform using weighted measures in five different categories to calculate annual state health rankings. Five-year averages from 2011 to 2015 of the health uninsured rate and 4-year averages from 2011 to 2014 of health spending per capita were obtained from the U.S. Census Bureau and Centers for Medicare & Medicaid Services. Linear regression analyses were performed to determine the associations between cancer survival value (CSV) = (1 – MIR) × 100% and state health variables.Results: During the study period, the 5-year averages of age-adjusted incidence, mortality rates, and CSVs were 60.3 ± 2.1 per 100,000 population, 43.4 ± 2.1 per 100,000, and 27.9 ± 3.9%, respectively. Among the 50 states, Connecticut had the highest CSV (38.6 ± 1.7%) whereas Nevada had the lowest CSV (18.7 ± 6.5%). Hawaii had the highest health ranking and Mississippi had the lowest ranking in 2016. States with better health rankings, lower health uninsured rates, and higher health spending were significantly associated with higher CSVs (R2 = 0.418, P < 0.001; R2 = 0.352, P < 0.001; R2 = 0.142, P = 0.007, respectively).Conclusions: There are significant differences in lung cancer survival within the United States. Lung cancer survival by using CSV was strongly associated with state health disparities, and it can be an applicable measure to evaluate the state-level health disparities in the United States.
topic lung cancer survival
America's Health Rankings
health economy (source: MeSH NLM)
insurance
disparity
url https://www.frontiersin.org/article/10.3389/fonc.2020.01449/full
work_keys_str_mv AT yuchelee stateleveldisparityinlungcancersurvivalintheunitedstates
AT yuchelee stateleveldisparityinlungcancersurvivalintheunitedstates
AT yuchelee stateleveldisparityinlungcancersurvivalintheunitedstates
AT rafaelacalderoncandelario stateleveldisparityinlungcancersurvivalintheunitedstates
AT rafaelacalderoncandelario stateleveldisparityinlungcancersurvivalintheunitedstates
AT gregoryeholt stateleveldisparityinlungcancersurvivalintheunitedstates
AT gregoryeholt stateleveldisparityinlungcancersurvivalintheunitedstates
AT michaelacampos stateleveldisparityinlungcancersurvivalintheunitedstates
AT michaelacampos stateleveldisparityinlungcancersurvivalintheunitedstates
AT mehdimirsaeidi stateleveldisparityinlungcancersurvivalintheunitedstates
AT mehdimirsaeidi stateleveldisparityinlungcancersurvivalintheunitedstates
AT mehdimirsaeidi stateleveldisparityinlungcancersurvivalintheunitedstates
_version_ 1724540321139785728